| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 18.954 | 83.320 | 159.082 | 180.442 | 245.765 | 311.390 |
| Total Income - EUR | - | - | - | - | 18.954 | 83.849 | 159.823 | 179.699 | 245.765 | 311.390 |
| Total Expenses - EUR | - | - | - | - | 6.032 | 29.075 | 38.323 | 45.746 | 35.752 | 87.908 |
| Gross Profit/Loss - EUR | - | - | - | - | 12.921 | 54.773 | 121.499 | 133.954 | 210.013 | 223.483 |
| Net Profit/Loss - EUR | - | - | - | - | 12.732 | 53.971 | 119.922 | 132.299 | 207.660 | 214.328 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ad Implantomax S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 31 | 2.944 | 5.438 | 9.169 | 5.630 | 56.017 |
| Current Assets | - | - | - | - | 13.775 | 59.578 | 116.774 | 163.002 | 203.253 | 188.234 |
| Inventories | - | - | - | - | 686 | 354 | 1.645 | 735 | 14.353 | 1.253 |
| Receivables | - | - | - | - | 0 | 377 | 5 | 106.514 | 57.754 | 7.642 |
| Cash | - | - | - | - | 13.090 | 58.848 | 115.125 | 55.753 | 131.146 | 179.339 |
| Shareholders Funds | - | - | - | - | 12.837 | 60.776 | 120.045 | 132.469 | 207.831 | 214.449 |
| Social Capital | - | - | - | - | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | 970 | 1.747 | 2.167 | 39.702 | 1.052 | 29.801 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ad Implantomax S.r.l.